Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Dinoprost
Listow Limited
QG02AD01
Dinoprost
Expired
Revised: October 2012 AN: 00754/2012 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cycloprost 5mg/ml Solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of product contains: ACTIVE SUBSTANCE(S): MG Dinoprost 5.00 EXCIPIENTS: Phenol 2.50 For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cycloprost is indicated for its luteolytic effect on corpora lutea in cattle. This luteolytic action of Cycloprost may be utilised as follows. 1. To improve control of the time of oestrus in cycling cattle. 2. To control breeding in cattle. 3. To induce parturition in cattle. 4. Synchronisation of recipient cattle for embryo transplantation. 5. To induce abortion in cattle. 6. To treat cattle which have a functional corpus luteum but do not express behavioural oestrus (sub-oestrus or silent heat). 7. For treatment of chronic metritis and pyometra in cattle. 8. For treatment of ovarian luteal cysts. 4.3 CONTRAINDICATIONS Do not administer by the intravenous route. Animals should not be treated if they suffer from either acute or sub acute disorders of the vascular system, gastrointestinal tract or respiratory system. Page 1 of 4 Revised: October 2012 AN: 00754/2012 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special warnings. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Cycloprost is ineffective when administered prior to day 5 after ovulation. Observe aseptic precautions during use. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Prostaglandins of the F 2 a type can be absorbed through the skin and may cause bronchospasm or miscarriage. Care should be taken when handling the product to AVOID SELF- INJECTION OR SKIN CONTACT. In case of accidental self-injection, seek medical advice immediately and show the packa Read the complete document